-
Jim QIU
Equity Partner / Shanghai
-
Tel +86-21-6061-3666
Email jimqiu@zhonglun.com
-
Practices

Compliance & Investigation, Investment/M&A & Corporate Governance, Private Equity & Investment Funds
-
Industries

Pharmaceuticals & Life Sciences, Healthcare, Telecom & Information
Jim QIU
Mr. Jim Qiu specializes in corporate compliance within the life sciences and healthcare sphere. He provides comprehensive compliance and risk management services to a diverse range of corporate clients. Leveraging an extensive track record, he advises on corporate compliance management and operations, the analysis, control, and mitigation of compliance risks, compliance reviews, compliance investigations, and due diligence. Furthermore, he offers strategic counsel and support for domestic and cross-border regulatory proceedings and compliance-related litigation.
Mr. Qiu serves as long-term legal counsel to numerous multinational and domestic Fortune 500 companies operating across the pharmaceutical, medical device, pharmaceutical services, and digital health sectors. His practice covers the entire lifecycle of healthcare and life sciences businesses, encompassing market access and regulatory supervision, licensing transactions, product R&D and clinical trial compliance, general healthcare regulatory compliance, product marketing, academic activities, healthcare professional (HCP) interactions, pharmacovigilance, medical device adverse events, digital health, medical e-commerce, and doctor-patient dispute resolution. Beyond the core healthcare sector, Mr. Qiu and his team possess substantial expertise in advising on health foods, cosmetics, foods for special medical purposes (FSMP), infant formula, and pet foods (including prescription pet diets).
Alongside his legal practice, Mr. Qiu serves as the Director of Professional Committee of Pharmaceutical and Healthcare Affairs of Shanghai Bar Association. He also acts as long-term external legal counsel to major medical associations and organizations in Shanghai, including the Shanghai Medical Association, and is a featured columnist for the Compliance Section of LexisNexis, a leading global publisher.
Representative Matters
Compliance and Regulation in Medical Healthcare Industry
Provided retainer-based general legal and compliance services to Sanofi for its China operations, covering both day-to-day matters and specific projects
Advised Merck Sharp & Dohme on a retainer basis regarding its China operations, covering general corporate and compliance matters
Provided retainer-based general legal services to the R&D division of BeiGene
Provided legal services, including regulatory compliance advice, to Roche regarding its digital marketing business
Assisted United Imaging with day-to-day compliance affairs and contract management
Provided retainer-based general legal and compliance services to Stryker in connection with its daily operations
Provided retainer-based general legal advice to Smith & Nephew regarding day-to-day compliance affairs
Provided retainer-based general legal services to Hoya/Pentax for its China operations, covering both day-to-day compliance and specific projects
Provided retainer-based general legal and compliance services to the healthcare division of ByteDance
Provided retainer-based general legal and compliance services to the Tencent Healthcare Affairs Division
Provided retainer-based general legal and compliance services to DXY regarding its China operations
Provided comprehensive, retainer-based general legal services to the Joint Administration Office of Shanghai Medical Organizations (including the Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, and Shanghai Nursing Association)
Assisted a U.S.-based global pharmaceutical company on a retainer basis in managing nationwide adverse event cases
Represented a U.S.-based pharmaceutical company in a product liability and drug quality dispute arising from adverse drug reactions
Represented a multinational pharmaceutical company in an indemnification dispute lawsuit involving subjects of multi-center clinical trials
Provided targeted compliance advice to a multinational pharmaceutical company regarding bid evaluation matters for the centralized volume-based procurement (VBP) of medicines
Provided targeted compliance advice to a renowned Israeli medical device company on the China market entry pathway for an innovative drug-device combination product
Represented a European multinational pharmaceutical company in leading a nationwide anti-corruption investigation into alleged bribery and enhancing its China compliance program
Advised a U.S.-based multinational medical device company on nationwide commercial bribery investigations
Compliance in Other Sectors
Represented Anheuser-Busch InBev in conducting compliance reviews and due diligence for multiple acquisition transactions in China
Assisted Anheuser-Busch InBev on a retainer basis with routine compliance reviews of new vendors
Advised listed company Luyang Energy-Saving Materials Co., Ltd. on a retainer basis regarding comprehensive compliance and risk management for its China operations
Assisted numerous U.S. and European multinational companies with internal anti-bribery investigations and the enhancement of compliance programs for their China operations
Advised numerous U.S. and European multinational companies on potential compliance risks associated with their China-based distribution networks and sales incentive programs
Provided anti-corruption and anti-bribery training to numerous multinational and domestic companies, advising on compliance remediation programs for their China operations
Provided nationwide legal support to numerous U.S. and European multinational companies in responding to government investigations across various compliance matters
Assisted several prominent U.S. and European manufacturing corporations in executing nationwide anti-counterfeiting enforcement programs
Advised a European multinational pharmaceutical company on responding to nationwide government investigations regarding alleged unfair competition violations
Represented a prominent European cosmetics company in a government investigation and subsequent compliance remediation program following a major safety incident
Represented a prominent U.S.-based chemical company in a government investigation regarding potential environmental violations
Honors and Awards
For Individual
Ranked in the healthcare sector, Chambers Greater China Region Legal Guide, 2023-2025
Outstanding Writer (Compliance Sector), LexisNexis, 2021
Recommended in healthcare and life sciences sector, Legal 500 Asia-Pacific, 2020-2024
China 100 A-list lawyers, China Business Law Journal, 2016
Memberships & Affiliations
Member, China Law Society and Shanghai Law Society
Director, Professional Committee of Pharmaceutical and Healthcare Affairs, Shanghai Bar Association
Member, Life Sciences Law Committee, Shanghai Law Society
Member, Competition Law Committee, Shanghai Law Society
Legal Counsel and Deputy Director, Legal Affairs Center, Shanghai Medical Ethics Association
Legal Counsel, Joint Administration Office of Shanghai Medical Organizations (the umbrella organization for the Shanghai Medical Association, Shanghai Medical Doctor Association, Shanghai Association of Traditional Chinese Medicine, Shanghai Nursing Association, etc.)
Columnist, Compliance Section, LexisNexis
Expert Consultant for Civil and Administrative Cases, Supreme People's Procuratorate
Legal Counsel to the Songjiang District People's Government, Shanghai
Specially Invited Mediator, Professional People's Mediation Center of Pudong New Area, Shanghai
Publications
"Research and Proposal on Medical Expenses Bearing System During Major Epidemics" (awarded in the essay competition held by Healthcare Legal Service Special Group of the All China Lawyers Association)
"Legitimate Handling of Medical Expenses During the Pandemic", official website of the Shanghai Bar Association (included in the Compilation of Studies on Legal Issues Against the Pandemic in the Field of Medicine and Healthcare by the Medical and Health Committee of the Shanghai Bar Association)
"Supervision and Legal Risks Regarding Online Diagnosis and Treatment", LexisNexis (also included in The Great Health Industry: Policy, Trends, and Legal Innovations published by Law Press China)
"Updates for You: New Rules for Online Diagnosis and Hospital Management", Wolters Kluwer
"Compliance Manual for Anti-Commercial Bribery Practices", LexisNexis
Related
-
Articles Related
Data Collection and Processing: Health and Genetic Data (China)
An overview of the regulatory requirements for cybersecurity and data protection in the Chinese healthcare industry. It focuses on data compliance issues that might be encountered by pharmaceutical companies and medical institutions, in particular regarding the requirements on data localisation and cross-border transfers of various types of healthcare data, including sensitive personal information (PI), human genetic resources (HGR) data, clinical trial data, medical records, and so on.
2023-07-20 -
Deals Related
-
Events Related
-
Awards Related
Zhong Lun Ranked in 42 Practice Areas and Regions with 178 Lawyer Rankings in the Chambers Greater China Region Guide 2026
On January 15, 2026, the internationally recognized legal ranking publisher Chambers & Partners released the Chambers Greater China Region Guide 2026. Zhong Lun Law Firm achieved rankings in 42 practice areas and regional categories, covering 31 practice areas and 11 regions, with 28 of those rankings placed in Band 1. In addition, 147 of the firm’s lawyers took home a total of 178 rankings.
2026-04-16
-
Bar Admissions/Professional Qualifications
PRC Bar
PRC Certified M&A Dealmaker -
Education
LL.M., University of Minnesota Law School, Minnesota, US
LL.B., East China University of Political Science and Law, Shanghai, China -
Professional Experience
Partner, Zhong Lun Law Firm
-
Languages
Chinese
English